Skip to main content
Caplight Logo









Lamark Biotech

Lamark Biotech

Private
AhmedabadHealthcare & Life Scienceshttps://lamarkbiotech.com/

Last Round

Seed

Jul 1, 2025

Total Funding Raised

$804,300

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Lamark Biotech is a biotechnology company that develops thermostable biologics using its proprietary ProteoStrong platform to reduce cold-chain dependency for life-saving therapeutics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Pharma Supply Chain

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

thermostable biologicscold-chain eliminationprotein stabilizationroom temperature drugsdrug formulationno-refrigeration medicineshelf-stable biologicsbiotech R&Dpharma supply chainmonoclonal antibodiesCDMOcontract developmentdrug accessibilitylast-mile pharma

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Lamark Biotech Comparables

Compare Lamark Biotech with similar companies based on industry and business-model similarity.

Lamark Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
EnsiliTech
86%
Jurata Thin Film
84%
Inaedis Inc.
79%

Lamark Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 1, 2025
SeedMar 22, 2021

Key People

Founding team and executive leadership

Vaibhav Bhatia

Chief Executive Officer, Founder

Founding Team

Lamark Biotech Investors

Notable investors and investment history

Lamark Biotech investors
InvestorRounds
IAN GroupSeed
VIT-Technology Business IncubatorSeed
BioAngelsSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    Monthly visitors increased 181% MoM, reaching 3K.

  • Jan 20, 2026

    Monthly visitors increased 1799% MoM, reaching 5.3K.

Lamark Biotech Filings

Explore SEC and related filing metadata, where available.

Lamark Biotech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Lamark Biotech's valuation, stock price, and market status.

Is Lamark Biotech a public or private company?

Lamark Biotech is a private company.

What is the current stock price of Lamark Biotech?

Lamark Biotech is a private company with no public stock price. Caplight tracks Lamark Biotech's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Lamark Biotech worth (valuation)?

Valuation information for Lamark Biotech is not publicly available.

Can I buy Lamark Biotech stock?

Lamark Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Lamark Biotech's last funding round?

Lamark Biotech's most recent funding round was Seed on July 1, 2025.

Who are the main investors in Lamark Biotech?

Key investors in Lamark Biotech include VIT-Technology Business Incubator.

Will Lamark Biotech IPO soon?

No public IPO plans have been announced for Lamark Biotech.

How can I track Lamark Biotech secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Lamark Biotech's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersAhmedabad
Employee Range11
Year Founded2018
Last FundingJul 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?